Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hypoxia Driven Metabolic Response in Oesophagogastric Adenocarcinoma

NCT06669663 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT06669663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06669663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hypoxia Driven Metabolic Response in Oesophagogastric Adenocarcinoma
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2024
Completion date
August 1, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oesophago-gastric carcinoma